XML 81 R63.htm IDEA: XBRL DOCUMENT v3.23.4
BUSINESS COMBINATIONS - Summary of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Jul. 28, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Liabilities assumed:        
Goodwill   $ 334,620 $ 44,489 $ 44,489
Obagi and Milk Business Combinations        
Total Purchase Price:        
Cash consideration $ 467,027      
Equity consideration 477,911      
Cash repayment of debt 140,047      
Total purchase consideration 1,107,085      
Fair value of assets acquired:        
Cash and cash equivalents 17,942      
Restricted cash 1,469      
Account receivable, net 19,080      
Related party receivable 526      
Inventories 61,971      
Prepaid expenses 4,827      
Other current assets 359      
Property and equipment 9,681      
Intangible assets 662,800      
Right-of-use assets 13,043      
Other assets 227      
Total identifiable assets acquired 791,925      
Liabilities assumed:        
Accounts payable and accrued expenses 25,141      
Other current liabilities 18,395      
Lease liabilities 16,566      
Deferred income tax liabilities 28,073      
Total liabilities assumed: 88,175      
Net assets acquired 703,750      
Purchase consideration 1,107,085      
Goodwill 403,335      
Obagi and Milk Business Combinations | Related Party        
Total Purchase Price:        
Related party liability 22,100      
Obagi        
Liabilities assumed:        
Goodwill   199,548 44,489 44,489
Obagi | Obagi and Milk Business Combinations        
Total Purchase Price:        
Cash consideration 345,398      
Equity consideration 277,824      
Cash repayment of debt 136,112      
Total purchase consideration 781,434      
Fair value of assets acquired:        
Cash and cash equivalents 15,850      
Restricted cash 650      
Account receivable, net 15,214      
Related party receivable 327      
Inventories 31,026      
Prepaid expenses 4,307      
Other current assets 359      
Property and equipment 1,245      
Intangible assets 505,300      
Right-of-use assets 4,811      
Other assets 227      
Total identifiable assets acquired 579,316      
Liabilities assumed:        
Accounts payable and accrued expenses 18,699      
Other current liabilities 12,912      
Lease liabilities 6,461      
Deferred income tax liabilities 28,073      
Total liabilities assumed: 66,145      
Net assets acquired 513,171      
Purchase consideration 781,434      
Goodwill 268,263      
Obagi | Obagi and Milk Business Combinations | Related Party        
Total Purchase Price:        
Related party liability 22,100      
Milk         
Liabilities assumed:        
Goodwill   $ 135,072 $ 0 $ 0
Milk  | Obagi and Milk Business Combinations        
Total Purchase Price:        
Cash consideration 121,629      
Equity consideration 200,087      
Cash repayment of debt 3,935      
Total purchase consideration 325,651      
Fair value of assets acquired:        
Cash and cash equivalents 2,092      
Restricted cash 819      
Account receivable, net 3,866      
Related party receivable 199      
Inventories 30,945      
Prepaid expenses 520      
Other current assets 0      
Property and equipment 8,436      
Intangible assets 157,500      
Right-of-use assets 8,232      
Other assets 0      
Total identifiable assets acquired 212,609      
Liabilities assumed:        
Accounts payable and accrued expenses 6,442      
Other current liabilities 5,483      
Lease liabilities 10,105      
Deferred income tax liabilities 0      
Total liabilities assumed: 22,030      
Net assets acquired 190,579      
Purchase consideration 325,651      
Goodwill 135,072      
Milk  | Obagi and Milk Business Combinations | Related Party        
Total Purchase Price:        
Related party liability $ 0